To analyze an association of Rep expression with clinic‐epidemiological parameters, we quantified the Rep (and CD68) expression in TMAs including tumor and paired tumor‐adjacent mucosa for each of the 246 patients with automated bright‐field IHC staining. The gene discussed is CD68; the disease is neoplasm.